The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors may possibly bring about an increase in oxycodone plasma concentrations, which could raise or extend adverse reactions and could trigger most likely fatal respiratory depression. Additionally, discontinuation of a concomitantly utilized cytochrome P450 3A4 inducer may poss